Mycoverse Raises €2.4M to Replace Pesticides with Fungal Crop Protection

Copenhagen-based agri-tech startup Mycoverse has secured €2.4 million in pre-seed equity financing to advance its biological crop protection platform. The company’s approach utilizes fungi to offer alternatives to traditional chemical pesticides, initially targeting potato late blight, a significant threat to European agriculture. This funding round, co-led by Future Food Fund and High-Tech Gründerfonds (HTGF), with participation from PINC, the venture arm of Finnish food company Paulig, brings Mycoverse’s total funding to approximately €4.3 million, including earlier support from Denmark’s BioInnovation Institute.

Bridging Microbiology, Agronomy, and Sustainable Farming

Mycoverse positions itself at the intersection of several key scientific disciplines. The company has developed a platform that combines fungal biology with artificial intelligence to identify naturally occurring fungal strains possessing protective properties against crop diseases. This isn’t simply about introducing fungi to fields; it’s a targeted approach leveraging the power of microbial interactions to bolster plant defenses. The core idea is to identify fungal metabolites – naturally produced compounds – that mimic the effects of chemical crop protection, but without the environmental drawbacks or the development of resistance in target organisms.

The initial focus on Phytophthora infestans, the pathogen responsible for potato late blight, is strategic. Late blight is a persistent and damaging disease, requiring repeated applications of chemical fungicides. Mycoverse aims to integrate its biological solution into existing spraying routines, minimizing disruption to current farming practices. Beyond potatoes, the company plans to expand its fungal solutions to other crops, including grapevines, as field trials progress. This expansion highlights the potential for a broader application of their technology across diverse agricultural systems.

How Mycoverse’s Platform Works

Mycoverse’s approach isn’t a random application of fungi. It’s a data-driven process. The company’s AI-driven discovery platform sifts through a vast library of fungal strains, identifying those with the most promising protective properties. This involves analyzing the fungal strains’ genetic makeup and metabolic outputs to pinpoint bioactive metabolites. These metabolites are then developed into crop protection solutions. Crucially, Mycoverse also focuses on scalable fungal production technology, ensuring that these biological solutions can be manufactured efficiently and cost-effectively to meet agricultural demands. This combination of discovery and production is key to translating laboratory success into real-world impact.

A Competitive Landscape

Mycoverse operates within a growing, but competitive, field. Although the company is pioneering a specific approach, it’s not alone in pursuing biological crop protection. Established agricultural chemical companies, such as BASF and Syngenta, are increasingly investing in biocontrol portfolios alongside their traditional synthetic products. BASF, for example, has a dedicated sustainable agriculture division. Smaller, specialized companies are also developing microbial or plant-derived treatments for specific diseases. This competitive landscape underscores the increasing recognition of the need for sustainable alternatives to conventional pesticides.

However, significant hurdles remain. Entrenched farming practices and the dominance of conventional fungicides present challenges to adoption. Farmers require consistent efficacy in diverse field conditions, and biological solutions must demonstrate comparable performance to chemical alternatives. The economic viability of these solutions is also critical; they must be priced competitively to encourage widespread adoption.

The European Context and Regulatory Pressure

The timing of Mycoverse’s funding is significant, coinciding with increasing regulatory pressure on chemical pesticides in Europe. The European Union is actively pursuing policies to reduce the use of synthetic pesticides and promote more sustainable agricultural practices. The EU’s Sustainable Use of Pesticides Directive aims to minimize risks to human health and the environment. This regulatory environment creates a structural opportunity for companies like Mycoverse, offering solutions that align with evolving policy goals.

For European investors, Mycoverse’s ability to attract both dedicated food-systems capital and deep tech investors signals continued interest in solutions that address these policy constraints. The company’s Danish origins, as a spin-out from the Technical University of Denmark (DTU), also highlight the role of research institutions in fostering innovation in the agritech sector. This blended public and private support is crucial for translating scientific discoveries into commercially viable products.

What’s Next for Mycoverse?

The €2.4 million in pre-seed funding will primarily support expanded field trials over the next two years. These trials are critical for validating the performance of Mycoverse’s solutions under commercial conditions and gathering data to support regulatory approval. The company will need to demonstrate consistent efficacy across diverse field conditions and prove that its biological alternatives can achieve commercial price points acceptable to growers.

The success of these field trials will determine whether Mycoverse can successfully scale its production and distribution, and contribute to a more sustainable agricultural system. As Europe’s regulatory landscape continues to evolve, startups that can bridge scientific innovation with practical farmer workflows will play a pivotal role in shaping the future of agricultural inputs. The next phase will test whether the promise of efficacy demonstrated in controlled environments translates into predictable performance at scale.